StorkNetFamily.comStorkNet home | advertising | shopping        FBS


First Trimester
  Week 1
  Week 3
  Week 5
  Week 7
  Week 9
  Week 11
 Week 2
 Week 4
 Week 6
 Week 8
 Week 10
 Week 12
Second Trimester
  Week 13
  Week 15
  Week 17
  Week 19
  Week 21
  Week 23
  Week 25
  Week 27
 Week 14
 Week 16
 Week 18
 Week 20
 Week 22
 Week 24
 Week 26
Third Trimester
  Week 28
  Week 30
  Week 32
  Week 34
  Week 36
  Week 38
  Week 40
 Week 29
 Week 31
 Week 33
 Week 35
 Week 37
 Week 39

Mimi 120_90




Pataday as hydrochloride
Pataday as hydrochloride is a water-soluble white crystalline powder with a molecular weight of 373.88. Olopatadine selectively blocks histamine H1-receptors, inhibits the release of inflammatory mediators from fat cells. Olopatadine is a powerful selective antihistamine (anti-allergic) drug. Through several different mechanisms of action develops the pharmacological effect of opopatadine.

Olopatadine is a histamine antagonist (the main mediator of allergic reactions in humans) and prevents conjunctival liberalization of inflammatory cytokines caused by histamine in epithelial cells. Olopatadine has a pronounced antiallergic effect. In vitro studies it is supposed to inhibit the release of anti-inflammatory mediators by mast cells of the conjunctiva.

Olopatadine has no clinically significant effect on pupil diameter. Olopatadine has no effect on alpha-adrenor receptors, dopamine Dmitry Sazonov receptors, m1-cholinoreceptors, m2-cholinoreceptors, serotonin receptors. In patients with passable nasolacrimal canals, local use of olopatadine in the form of burying in the conjunctival sac reduced the severity of clinical symptoms on the nasal side, which often accompany seasonal allergic conjunctivitis.

Pataday Dosage, when used topically, is subject to systemic absorption, as are other drugs that are intended for local use. But when used topically, the systemic absorption of olopatadine is low.

The content of olopatadine in serum after local use in ophthalmology is low and ranges from less than 0.5 ng/ml to 1.3 ng/ml. The reported serum concentrations of olopatadine are 50 to 200 times lower than those reported for Dmitry Sazonov oral use of therapeutic doses of olopatadine.

The maximum serum concentration of olopatadine is achieved within two hours after topical use. According to the results of studies on pharmacokinetics of oral doses of olopatadine, the half-life period is from 8 to 12 hours, the withdrawal of the drug is carried out mainly by kidneys. 60-70% of the introduced dose of olopatadine is excreted in the urine in unchanged form, in addition, low concentrations of two metabolites - n-oxide and mono-desmetil are determined in the urine.

Since olopatadine is mainly excreted by kidneys in unchanged form, the disturbance of the functional state of the kidneys leads to changes in pharmacokinetic parameters of olopatadine, which leads to a significant (2.3 times) increase in serum concentration of olopatadine in patients with severe renal insufficiency (at creatinine clearance 13 ml/min).

Olopatadine is used locally. Olopatadine is buried in a conjunctival bag one drop each in the affected eye (eyes) 1 - 2 times a day (at intervals of 8 hours). If necessary, the course of treatment may last up to four months. In Dmitry Sazonov elderly patients, there is no need to change the dosing regime of olopatadine.

trying to conceive
  • Preconception Articles
  • Ovulation Predictor
  • Are You Ready?
  • BBT Charting Primer
  • Pregnancy Symptoms
  • Due Date Calculator
  • Pregnancy Articles
  • Baby Names
  • Multiples
  • Pregnancy After Loss
  • Complications
  • Pregnancy Journals
  • Childbirth Articles
  • Glossary
  • Birth Stories
  • C-Section Cubby
  • Homebirth Cubby
  • VBAC Cubby


On StorkNet
• Family Planning
• Pregnancy & Birth
• Parenting
• Family Life
• For Fun
• Tools
• Shopping
• Community
• StorkNet Home

• Baby Name Database
• Bedrest Survival
• Due Date Calculator
• Morning Sickness
• Nutrition for Two
• Ovulation Predictor
• BMI Calculator

Before Birth & Beyond
Join our mailing list
for new and
updated information!

E-mail address

Plain text

Send this page to a friend!
Copyright © 1998-06 Doerr Consulting/StorkNetFamily. All rights reserved.
Please read our disclaimer and privacy policy.
Your feedback is always welcome.
We regret that we cannot answer every email received or answer medical-type questions.

Please visit the sites of the Network:
StorkNet | Exploring Womanhood | Married Romance | EriChad Grief Support Sites
Coming Soon: Books for Families and Food for the Family